The hearing implant maker’s share price cratered to the lowest level since April 2016 after it warned that softer global ...
Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...
The medical device manufacturer has delivered a bitter pill for shareholders. The post Why are Cochlear shares down 36% today ...
April 22 (Reuters) - Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast for annual earnings, citing weak trading ...
Cochlear, an Australian hearing implant manufacturer, has slashed its 2026 earnings forecast due to the Middle East conflict, resulting in a nearly 39% drop in share value. The turmoil has affected ...
In mammals, sounds are perceived through mechanosensory hair cells located within the sensory epithelium of the cochlea (the organ of Corti). Hair cells produced during development are postmitotic and ...
Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long ...
The U.K.’s Competition and Markets Authority is escalating its investigation into Cochlear’s planned acquisition of Demant subsidiary Oticon Medical, based on concerns that the merger could stanch ...
For decades, hearing experts thought that the cochlea's spiral shape was simply an efficient packing job and its shape had no effect on how this critical hearing organ functions. But a recent study by ...
Apple has teamed up with Australian-based Cochlear to bring iPhone users the first made for iPhone Cochlear implant. Approved by the U.S. Food and Drug Administration in June, Cochlear’s Nucleus 7 ...
Approval also includes extending the Nucleus 7 Sound Processor to the first U.S. cochlear implant recipients, Custom Sound Pro fitting software to enhance support for hearing professionals LONE TREE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results